CYAB Cyabra, Inc. - Common Stock
NASDAQ · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 13, 2026
$0.20
· of 52w range
· above low
· to high
$0.1952w low
$1.8752w high
EPS
$-156.35
your badges
52W Range
$0–$2
Analyst Rating
BUY
Price Target
$1
P/E
·
ROE
118.5%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
CYAB Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.20
EPS
$-156.35
ROE
118.5%
Debt/Equity (MRQ)
-0.2
52W Range
$0–$2
CYAB Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
EPS$-156.352025-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | CYAB | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROE | 118.5% | · | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | CYAB | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | -0.2 | · | · | · | |
| Current Ratio (MRQ) | 0.1 | · | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 |
|---|---|---|
| Operating Expenses | $156.3K | |
| Operating Income | $-156.3K | |
| Net Income | $-156.3K | |
| EPS (Basic) | $-156.35 | |
| EPS (Diluted) | $-156.35 | |
| Shares (Basic) | 1,000 | |
| Shares (Diluted) | 1,000 | |
| EBITDA | $-156.3K |
Balance Sheet
| Metric | Trend | 2025 |
|---|---|---|
| Cash & Equivalents | $294.0K | |
| Receivables | $269.0K | |
| Other Current Assets | $152.0K | |
| Current Assets | $737.0K | |
| PP&E (Net) | $146.0K | |
| Total Assets | $1M | |
| Accounts Payable | $2M | |
| Accrued Liabilities | $476.0K | |
| Short-term Debt | $6M | |
| Current Liabilities | $25M | |
| Capital Leases | $268.0K | |
| Total Liabilities | $26M | |
| Retained Earnings | $-47M | |
| Stockholders' Equity | $-40M | |
| Liabilities + Equity | $1M | |
| Shares Outstanding | 3,019,557 |
Profitability
| Metric | Trend | 2025 |
|---|---|---|
| ROE | 118.5% |
Per Share
| Metric | Trend | 2025 |
|---|---|---|
| Book Value / Share | $-210.17 | |
| EPS (TTM) | $-156.35 |
Valuation (TTM)
| Metric | Trend | 2025 |
|---|---|---|
| Net Income TTM | $-156.3K |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Revenue | $2M | $1M | $1M | $1M | |
| Cost of Revenue | $304.0K | $192.0K | $213.0K | $196.0K | |
| Gross Profit | $2M | $1M | $1M | $1M | |
| R&D Expense | $2M | $6M | $2M | $2M | |
| SG&A Expense | $1M | $6M | $1M | $2M | |
| Operating Income | $-3M | $-12M | $-3M | $-4M | |
| Other Non-op | $-255.0K | · | $992.0K | · | |
| Pretax Income | $-3M | $-11M | $-2M | $-3M | |
| Income Tax | $64.0K | · | $19.0K | · | |
| Net Income | $-3M | $-11M | $-2M | $-3M | |
| EPS (Basic) | $-0.26 | $-3.10 | $-1.07 | $-1.47 | |
| EPS (Diluted) | $-0.26 | $-3.10 | $-1.07 | $-1.47 | |
| Shares (Basic) | 13,390,609 | 3,471,031 | 2,435,385 | 2,356,837 | |
| Shares (Diluted) | 13,790,609 | 3,471,031 | 2,435,385 | 2,356,837 | |
| EBITDA | $-3M | $-12M | · | · |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $794.0K | $3M | · | · | |
| Receivables | $568.0K | $216.0K | · | · | |
| Other Current Assets | $593.0K | $241.0K | · | · | |
| Current Assets | $2M | $4M | · | · | |
| PP&E (Net) | $144.0K | $137.0K | · | · | |
| Other Non-current Assets | $99.0K | $125.0K | · | · | |
| Total Assets | $3M | $5M | · | · | |
| Accounts Payable | $2M | $2M | · | · | |
| Accrued Liabilities | $2M | $5M | · | · | |
| Short-term Debt | $2M | $2M | · | · | |
| Current Liabilities | $14M | $16M | · | · | |
| Capital Leases | $95.0K | $169.0K | · | · | |
| Total Liabilities | $15M | $17M | · | · | |
| Total Debt | $2M | $2M | · | · | |
| Retained Earnings | $-62M | $-58M | · | · | |
| Stockholders' Equity | $-12M | $-12M | · | · | |
| Liabilities + Equity | $3M | $5M | · | · | |
| Shares Outstanding | · | 14,064,191 | · | · |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Stock-based Comp | $223.0K | $4M | $866.0K | $1M | |
| Operating Cash Flow | $-2M | $-3M | $-3M | $-1M | |
| CapEx | $23.0K | $5.0K | $17.0K | $12.0K | |
| Investing Cash Flow | $-23.0K | $-5.0K | $-17.0K | $-12.0K | |
| Financing Cash Flow | $-60.0K | $6M | $2M | $1M | |
| Free Cash Flow | · | $-3M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Gross Margin | 83.6% | 86.4% | · | · | |
| Operating Margin | -168.4% | -835.6% | · | · | |
| Net Margin | -185.6% | -761.1% | · | · | |
| Pretax Margin | -182.1% | -761.1% | · | · | |
| EBITDA Margin | -168.4% | -835.6% | · | · | |
| ROA | -261.3% | -475.8% | · | · | |
| ROE | 57.3% | 178.8% | · | · | |
| ROIC | 31.8% | · | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Current Ratio | 0.1 | 0.2 | · | · | |
| Quick Ratio | 0.1 | 0.2 | · | · | |
| Debt / Equity | -0.2 | -0.2 | · | · |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Asset Turnover | 1.4 | 0.6 | · | · | |
| Receivables Turnover | 6.5 | 13.1 | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Book Value / Share | · | $-0.86 | · | · | |
| Revenue / Share | $0.13 | $0.41 | · | · | |
| Cash Flow / Share | · | $-0.75 | · | · | |
| Cash / Share | · | $0.22 | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 |
|---|---|
| Net Income | $-156.3K |
| Diluted EPS | $-156.35 |
No data for this statement
Not enough fundamentals data to build this statement yet.
No data for this statement
Not enough fundamentals data to build this statement yet.
Activists & 5%+ owners 3 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Yossef Daar | April 3, 2026 | 5.10% | Initial filing | Passive investment | SEC |
| Dan Brahmy | April 3, 2026 | 5.10% | Initial filing | Passive investment | SEC |
| Ido Shraga | April 3, 2026 | 5.10% | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 10 insiders · 5 officers · 7 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Dan Brahmy | Chief Executive Officer | July 10, 2026 P | 853,052 | 3 | 0 | $74,573 |
| Yael Sandler | Chief Financial Officer | May 14, 2026 A | 40,000 | 0 | 0 | $0 |
| Ido Shraga | Chief Technology Officer | July 10, 2026 P | 894,199 | 2 | 0 | $50,967 |
| Yossef Daar | Chief Product Officer | July 10, 2026 P | 894,199 | 2 | 0 | $50,967 |
| Emmanuel Heymann | Chief Revenue Officer | May 14, 2026 A | 100,000 | 0 | 0 | $0 |
| James Francis Flanagan | Director | July 10, 2026 P | 224,940 | 2 | 0 | $109,193 |
| Sonny Vu | Director | May 14, 2026 A | 107,329 | 0 | 0 | $0 |
| Madon Michael P | Director | May 14, 2026 A | 100,000 | 0 | 0 | $0 |
| Michael Pompeo | Director | March 27, 2026 A | · | 0 | 0 | $0 |
| Josette Sheeran | Director | March 27, 2026 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
CYAB Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 7 analysts
BUY
Median target
$1.00
+397.0%
2 28.6%
Strong Buy
4 57.1%
Buy
1 14.3%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
2 analysts · 2026-09-30Mean target $1.00 +397.0%
Low$1.00
Mean$1.00
High$1.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 13, 2026